The history of cathepsin drug discovery has in fact witnessed the development of pharmacological cathepsin inhibitors, especially for cathepsin K during inflammatory conditions, as for osteoporosis or arthritis (143). This evidence concerns the gene CTSS and arthritic joint disease.